Though cannabidiol (CBD) has long been recognized in the oncological field as a palliative therapeutic agent, only recently has it been demonstrated to induce anti-tumor responses in breast cancer. To learn more, Dr. Matt Birnholz is joined by Dr. Luka Dobovisek, whose recent study looked at the effect of CBD on cell viability of selected breast cancer cell lines, both as a single agent and in combinations with breast cancer therapies such as tamoxifen.